The CtGNPs were selected as a core of this delivery system because it inhibits [51] tumor growth and metastasis by negating MAPK-signaling, up-regulating E-cadherin, and down-regulating Snail, N-Cadherin, and Vimentin. The gene discussed is CDH2; the disease is neoplasm.